Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.

• 伴有IDH1或IDH2基因突变的肿瘤具有独特的遗传学和临床特点，病人比野生型IDH基因的肿瘤病人预后好。